Target intelligence / Profile preview

Alpha-Klotho messenger RNA (KL mRNA) (KL mRNA)

Target
KL mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Alpha-Klotho messenger RNA (KL mRNA) is the transcript of the KL gene, which encodes the alpha-Klotho protein, a critical regulator of aging and mineral metabolism [UniProt Q9UEF7]. Primarily expressed in the renal distal convoluted tubules and the choroid plexus of the brain, Klotho acts as an essential co-receptor for fibroblast growth factor 23 (FGF23) to maintain phosphate and vitamin D homeostasis [Nature Reviews Nephrology, 2019]. Beyond its role in mineral metabolism, Klotho functions as a circulating hormone with potent anti-oxidative, anti-inflammatory, and anti-senescence properties [JASN, 2011]. A decline in Klotho expression is a hallmark of chronic kidney disease (CKD) and is associated with accelerated aging, cardiovascular complications, and cognitive decline [Nature Reviews Nephrology, 2009]. Therapeutic approaches utilizing Klotho-encoding mRNA aim to restore endogenous protein levels through transient expression, offering a potential strategy to mitigate the progression of age-related and metabolic diseases [Molecular Therapy, 2020]. This modality is particularly attractive because it avoids the genomic integration risks associated with DNA-based gene therapy while providing the necessary protein for systemic or local action. Current research focuses on optimizing lipid nanoparticle (LNP) delivery systems to target the kidneys or liver for sustained protein secretion.

Other names
Klotho-encoding messenger RNAKL mRNAalpha-Klotho mRNAKlotho transcriptKLS mRNA
02

Mechanism of action

Translation of exogenous mRNA into functional alpha-Klotho protein to restore physiological signaling and cytoprotective functions.

03

Biological functions

Phosphate homeostasisAging regulationVitamin D metabolismOxidative stress protectionInsulin signaling modulation
04

Disease associations

Chronic kidney diseaseAlzheimer's diseaseCardiovascular diseaseOsteoporosisSenescence-related disorders
05

Safety considerations

Lipid nanoparticle (LNP) mediated toxicityInnate immune activation via Toll-like receptors (TLR7/8)Potential for hyperphosphatemia due to excessive Klotho activityTransient nature of mRNA expression requiring repeated dosing
06

Interacting drugs

Investigational mRNA-based Klotho replacement therapy
07

Biomarkers

Serum alpha-Klotho protein levelsFibroblast growth factor 23 (FGF23) levelsSerum phosphate levels1,25-dihydroxyvitamin D3 levels

Beyond the preview

Go deeper on Alpha-Klotho messenger RNA (KL mRNA) (KL mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-Klotho messenger RNA (KL mRNA) (KL mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call